Mesoblast | MSB - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Avita Medical AUD 10.24M 1.98M 2025-12
Clinuvel Pharmaceuticals AUD 35.2M 3.62M 2024-06
Cochlear AUD 275.7M 107.4M 2025-06
CSL USD 2.16B 633M 2025-06
Pacific Edge NZD 29.26M 8.79M 2024-06
Paradigm Biopharmaceuticals AUD 16.82M 1M 2025-06
PYC Therapeutics AUD 153.05M 103.8M 2025-06
Ramsay Health Care AUD 784.4M 443.3M 2025-06
Sonic Healthcare AUD 645M 25.39M 2024-06
Starpharma Holdings AUD 15.41M 4.87M 2025-06
Telix Pharmaceuticals AUD 141.87M 65.29M 2025-12